Cutaneous manifestations of category A bioweapons

Journal of the American Academy of Dermatology

Volumn 65, Issue 6, 2011, Pages 1213.e1-1213.e15

  Aquino, Lisa L ^a   Wu, Jashin J ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

anthrax; bioterrorism; fever; plague; public health; smallpox; tularemia; viral hemorrhagic

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIDOFOVIR; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; HYPERTENSIVE FACTOR; MYCOTOXIN; QUINOLONE DERIVATIVE; RIBAVIRIN; STREPTOMYCIN;

ANTHRAX; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BOTULISM; BUBONIC PLAGUE; CLOSTRIDIUM PERFRINGENS; ECCHYMOSIS; ERYTHEMA; FLUID THERAPY; FRANCISELLA TULARENSIS; GANGRENE; GLANDERS; HANTAVIRUS; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; MELIOIDOSIS; MORBIDITY; MORTALITY; NONHUMAN; ORNITHOSIS; ORTHOPOXVIRUS; PAPULE; PLAGUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH; PUNCH BIOPSY; Q FEVER; RNA VIRUS; SALMONELLA TYPHI; SKIN ANTHRAX; SKIN MANIFESTATION; SMALLPOX; TUBERCULOSIS; TULAREMIA; TYPHUS; UNITED STATES; YELLOW FEVER FLAVIVIRUS; YERSINIA PESTIS;

EID: 81155131119     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.08.040     Document Type: Review

References (65)

1. J. Jernigan, D.S. Stephens, D.A. Ashford, C. Omenaca, M.S. Topiel, and M. Galbraith Bioterrorism-related inhalational anthrax Emerg Infect Dis 7 2001 933 944
2. S. Hsu Modest gains against ever-present bioterrorism threat Washington Post August 3, 2008 A10
3. M.K. Jacobs The history of biological warfare and bioterrorism Dermatol Clin 22 2004 231 246
4. C. Carroll, R. Balkrishnan, V. Khanna, and S. Feldman Bioterrorism preparedness in the dermatology community Arch Dermatol 139 2003 1657 1658
5. S.C. Alder, J.D. Clark, G.L. White, S. Talboys, and S. Mottice Physician preparedness for bioterrorism recognition and response: a Utah-based needs assessment Disaster Manag Response 2 2004 69 74 (Pubitemid 39069406)
6. American Academy of Dermatology. Disaster Preparedness. Available at: http://www.aad.org/members/disaster/bioterrorism/index.html. Accessed February 13, 2011.
7. Robinson JP, Cosivi O, Davey BJ, Hay AWM, Kenyon IR, Krutzsch W, et al. Public health response to biological and chemical weapons: WHO guidance. 2004. Available at: http://www.who.int/csr/delibepidemics/biochemguide/en/index.html. Accessed August 12, 2009.
8. WHO Group of Consultants Health aspects of chemical and biological weapons 1970 World Health Organization Geneva (Switzerland)
9. Emergency Preparedness and Response. Bioterrorism. Available at: http://www.bt.cdc.gov/bioterrorism/. Accessed February 13, 2011.
10. M.R. Grey, and K.R. Spaeth The bioterrorism sourcebook 2006 McGraw-Hill New York
11. T.W. McGovern, G.W. Christopher, and E.M. Eitzen Cutaneous manifestations of biological warfare and related threat agents Arch Dermatol 135 1999 311 322 (Pubitemid 29159214)
12. R.D. LeClaire, and M.L.M. Pitt Biological weapons defense: infectious diseases and counterbioterrorism 2005 Humana Press Totowa (NJ) p. 41-60
13. Arizona Department of Health Services. Epsilon Toxin of Clostridium Perfrigens. Available at: http://www.azdhs.gov/phs/edc/edrp/pdf/epsilontoxinset. pdf. Accessed February 13, 2011.
14. H. Tissot Dupont, D. Raoult, P. Brouqui, F. Janbon, D. Peyramond, and P.J. Weiller Epidemiological features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases Am J Med 93 1992 427 434
15. M.B. Van Hensbroek, E. de Vries, G. Dolan, and P. Schneeberger Rash and petechiae as presenting signs of Q fever Pediatr Infect Dis J 19 2000 358 (Pubitemid 30213080)
16. J.J. Wu, D.B. Huang, K.R. Pang, and S.K. Tyring Rickettsial infections around the world, part 2: rickettsialpox, the typhus group, and bioterrorism J Cutan Med Surg 19 2005 105 115
17. A. Mushtaq, M. El-Azizi, and N. Khardori Category C potential bioterrorism agents and emerging pathogens Infect Dis Clin North Am 20 2006 423 441 (Pubitemid 43817448)
18. G.J. Moran Threats in bioterrorism II: CDC category B and C agents Emerg Med Clin North Am 20 2002 311 330 (Pubitemid 34753113)
19. W. Muranyi, U. Bahr, M. Zeier, and F.J. van der Woude Hantavirus infection J Am Soc Nephrol 16 2005 3669 3679 (Pubitemid 46211288)
20. W.B. Hengold Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins Dermatol Clin 22 2004 257 262
21. R.A. Etzel Mycotoxins Jama 287 2002 425 427 (Pubitemid 34251974)
22. J.A. Witkowski, and L.C. Parish The story of anthrax from antiquity to the present: a biological weapon of nature and humans Clin Dermatol 20 2002 336 342
23. Infectious Disease Society of America. Biodefense Information and Resources. Available at: http://www.idsociety.org/bt/toc.htm. Accessed February 13, 2011.
24. M. Meselson, J. Guillemin, M. Hugh-Jones, A. Langmuir, I. Popova, and A. Shelokov The Sverdlovsk anthrax outbreak of 1979 Science 255 1994 1202 1208 (Pubitemid 24371272)
25. Norton S. Bioterrorism and the dermatologist: a newsmaker interview with Scott Norton. 2002. Available at: http://www.medscape.com/viewarticle/439902. Accessed August 12, 2009.
26. American Academy of Dermatology Ad Hoc Task Force on Bioterrorism. Cutaneous Anthrax Management Algorithm. Available at: http://www.aad.org/ members/disaster/bioterrorism/bio-anthrax-cutaneous.html. Accessed February 13, 2011.
27. T.V. Inglesby, D.A. Henderson, J.T. Bartlett, M.S. Ascher, E. Eitzen, and A.M. Friedlander Anthrax as a biological weapon JAMA 281 1999 1735 1745
28. Committee on Infectious Diseases The use of systemic fluoroquinolones Pediatrics 118 2006 1287 1292
29. Food and Drug Administration. Postmarket Drug Safety Information for Patients and Providers. Information for Health Care Professionals. May 29, 2010. Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm126085.htm. Accessed February 13, 2011.
30. R.G. Darling, C.L. Catlett, K.D. Huebner, and D.G. Jarret Threats in bioterrorism I: CDC category A agents Emerg Med Clin North Am 20 2002 273 309 (Pubitemid 34753112)
31. T.V. Inglesby, D.T. Dennis, D.A. Henderson, J.G. Bartlett, M.S. Ascher, and E. Eitzen Plague as a biological weapon: medical and public health management JAMA 283 2000 2281 2289
32. Plague Fact Sheet. Center for Biosecurity of UPMC. Available at: http://www.upmc-biosecurity.org/website/focus/agents-diseases/fact-sheets/ plague.html. Accessed February 13, 2011.
33. N.E. Kman, and R.N. Nelson Infectious agents of bioterrorism: a review for emergency physicians Emerg Med Clin North Am 26 2008 517 547 (Pubitemid 351491563)
34. M.S. Bronze, M.M. Huycke, L.J. Machado, G.W. Voskuhl, and R.A. Greenfield Viral agents as biological weapons and agents of bioterrorism Am J Med Sci 323 2002 316 325 (Pubitemid 34651569)
35. A. Wollenberg, and R. Engler Smallpox, vaccination and adverse reactions to vaccine Curr Opin Allergy Clin Immunol 4 2004 271 275 (Pubitemid 39006841)
36. World Health Organization. Smallpox. Available at: http://www.who.int/ csr/disease/smallpox/en/. Accessed February 13, 2011.
37. A.R. Rao Smallpox 1972 Kothari Book Depot Bombay
38. M. Karwa, B. Currie, and V. Kvetan Bioterrorism: preparing for the impossible or improbable Crit Care Med 33 2005 S75 S95
39. Z.S. Moore, J.F. Seward, and J.M. Lane Smallpox Lancet 267 2006 425 435 (Pubitemid 43184265)
40. D. Baxby Poxviruses R.B. Belshe, Textbook of human virology 1984 PSG Publishing Co Littleton (MA) 929 948
41. D.T. Dennis, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, and E. Eitzen Tularemia as a biological weapon: medical and public health management JAMA 285 2001 2763 2773 (Pubitemid 32525374)
42. R.F. Jacobs Tularemia Adv Pediatr Infect Dis 12 1997 55 69
43. R. Langley, and R. Campbell Tularemia in North Carolina, 1965-1990 N C Med J 56 1995 314 317
44. Centers for Disease Control and Prevention Biological and chemical terrorism: strategic plan for preparedness and response: recommendations of the CDC Strategic Planning Workgroup MMWR Recomm Rep 49 2000 1 14
45. M.E. Evans, and A.M. Friedlander Tularemia F.R. Sidell, E.T. Takafuji, D.R. Franz, Medical aspects of chemical and biological warfare 1997 TMM Publications Washington (DC) 503 512
46. L.E. Nigrovic, and S.L. Wingerter Tularemia Infect Dis Clin North Am 22 2008 489 504
47. E. Francis Tularemia Jama 84 1925 1243 1250
48. P. Bossi, D. Garin, A. Guihot, F. Gay, J.M. Crance, and T. Debort Bioterrorism: management of major biologic agents Cell Mol Life Sci 63 2006 2196 2212 (Pubitemid 44653033)
49. K. Alibek Biohazard 1999 Random House New York p. 29-38
50. A. Sjostedt Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations Ann N Y Acad Sci 1105 2007 1 29 (Pubitemid 47507090)
51. J.F. Bell Tularemia J.H. Steele, CRC handbook series in zoonoses Vol 2 1980 CRC Press Boca Raton (FL) 161 193
52. L. Borio, T. Inglesby, C.J. Peters, A.L. Schmaljohn, J.M. Hughes, and P.B. Jahrling Hemorrhagic fever viruses and biologic weapons: medical and public health management JAMA 287 2002 2391 2405 (Pubitemid 34493202)
53. D.C. Piggot Hemorrhagic fever viruses Crit Care Clin 21 2005 765 783
54. M.R. Salvaggio, and J.W. Baddley Other viral bioweapons: Ebola and Marburg hemorrhagic fever Dermatol Clin 22 2004 291 302 (Pubitemid 38781725)
55. R.N. Charrel, and X. de Lamballerie Arenaviruses other than Lassa fever virus Antiviral Res 57 2003 89 100 (Pubitemid 36254723)
56. N. Curtis Viral hemorrhagic fevers caused by Lassa, Ebola, and Marburg viruses Adv Exp Med Biol 582 2006 35 44
57. World Health Organization. Acute hemorrhagic fever syndrome. Available at: http://www.who.int/csr/resources/publications/surveillance/ whocdscsrisr992syn.pdf. Accessed August 12, 2009.
58. A.M. Friedlander, S.L. Welkos, M.L. Pitt, J.W. Ezzel, P.L. Worsham, and K.J. Rose Postexposure prophylaxis against experimental inhalation anthrax J Infect Dis 167 1993 1239 1242
59. D.R. Franz, P.B. Jahrling, A.M. Friedlander, D.J. McClain, D.L. Hoover, and W.R. Bryne Clinical recognition and management of patients exposed to biological warfare agents JAMA 278 1997 399 411 (Pubitemid 27327459)
60. D. Kelly, J.D. Chulay, P. Mikesell, and A. Friedlander Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys J Infect Dis 166 1992 1184 1187
61. D.A. Henderson, T.V. Inglesby, and J.G. Bartlett Smallpox as a biological weapon: medical and public health management JAMA 281 1999 2127 2137 (Pubitemid 29264692)
62. W.L. Mason, H.T. Eigelsbach, S.F. Little, and J.H. Bates Treatment of tularemia, including pulmonary tularemia, with gentamicin Am Rev Respir Dis 121 1980 39 45 (Pubitemid 10142397)
63. P. Russell, S.M. Eley, M.J. Fulop, D.L. Bell, and R.W. Titball The efficacy of ciprofloxacin and doxycycline against experimental tularemia J Antimicrob Chemother 41 1998 461 465 (Pubitemid 28167505)
64. A.P. Limaye, and C.J. Hooper Treatment of tularemia with fluoroquinolones: two cases and review Clin Infect Dis 29 1999 922 924 (Pubitemid 30256390)
65. J.B. McCormick, I.J. King, P.A. Webb, C.L. Scribner, R.B. Craven, and K.M. Johnson Lassa fever: effective therapy with ribavirin N Engl J Med 314 1986 20 26 (Pubitemid 16183064)